- Home
- Publications
- Publication Search
- Publication Details
Title
Nebenwirkungen der Immun-Checkpoint-Inhibitoren
Authors
Keywords
Immuntherapie, Kortikosteroide, Nebenwirkungen, immunvermittelte, PD-1-Inhibitor, PD-L1-Inhibitor, Immunotherapy , Corticosteroids, Adverse events, immune-mediated, PD-1 inhibitor, PD-L1 inhibitor
Journal
UROLOGE
Volume 56, Issue 4, Pages 486-491
Publisher
Springer Nature
Online
2017-02-28
DOI
10.1007/s00120-017-0342-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pneumonitis in Patients Treated With Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy
- (2017) Jarushka Naidoo et al. JOURNAL OF CLINICAL ONCOLOGY
- Elevated Liver Enzymes: Emergency Department–Focused Management
- (2017) Eric Sulava et al. JOURNAL OF EMERGENCY MEDICINE
- Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapy
- (2016) Thomas K. Eigentler et al. CANCER TREATMENT REVIEWS
- Management of toxicities of immune checkpoint inhibitors
- (2016) Lavinia Spain et al. CANCER TREATMENT REVIEWS
- Medikamentös-toxische Lebererkrankungen
- (2016) Hans Spangenberg DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
- Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor
- (2016) V.R. Belum et al. EUROPEAN JOURNAL OF CANCER
- Immune-related adverse events with immune checkpoint blockade: a comprehensive review
- (2016) J.M. Michot et al. EUROPEAN JOURNAL OF CANCER
- Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
- (2016) Stefan R. Bornstein et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
- (2016) Jonathan E Rosenberg et al. LANCET
- Therapiemonitoring und Nebenwirkungsmanagement bei PD-1/PD-L1-Immuncheckpoint-Inhibition
- (2016) H. Oppel-Heuchel et al. UROLOGE
- Nivolumab-associated acute glomerulonephritis: a case report and literature review
- (2016) Kyungsuk Jung et al. BMC Nephrology
- Therapiemonitoring und Nebenwirkungsmanagement bei PD-1/PD-L1-Immuncheckpoint-Inhibition
- (2016) H. Oppel-Heuchel et al. UROLOGE
- Evaluation of immune infiltration in the colonic mucosa of patients with ipilimumab-related colitis
- (2016) Edurne Arriola et al. OncoImmunology
- Ipilimumab-associated Hepatitis
- (2015) Melanie Johncilla et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Anti–PD-1–Related Pneumonitis during Cancer Immunotherapy
- (2015) Mizuki Nishino et al. NEW ENGLAND JOURNAL OF MEDICINE
- The risk of rash associated with ipilimumab in patients with cancer: A systematic review of the literature and meta-analysis
- (2013) Kira Minkis et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search